Cargando…
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
AIMS: The recent outbreak of COVID-19 has become a global health concern. There are currently no effective treatment strategies and vaccines for the treatment or prevention of this fatal disease. The current study aims to determine promising treatment options for the COVID-19 through a computational...
Autores principales: | Mousavi, Seyedeh Zahra, Rahmanian, Mojdeh, Sami, Ashkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598903/ https://www.ncbi.nlm.nih.gov/pubmed/33130005 http://dx.doi.org/10.1016/j.meegid.2020.104610 |
Ejemplares similares
-
Organ-specific or personalized treatment for COVID-19: rationale, evidence, and potential candidates
por: Mousavi, Seyedeh Zahra, et al.
Publicado: (2022) -
In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19
por: Mirmohammadi, SeyedehMozhdeh, et al.
Publicado: (2022) -
Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
por: Mirmohammadi, Seyedeh Mozhdeh, et al.
Publicado: (2022) -
L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies
por: Sendama, Wezi
Publicado: (2020) -
K-Map: connecting kinases with therapeutics for drug repurposing and development
por: Kim, Jihye, et al.
Publicado: (2013)